Memorial Sloan Kettering Cancer Center is a clinical research site located in Commack, New York, United States 11725.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Memorial Sloan Kettering Cancer Center has participated in 10 clinical trials with 3 currently active.
Therapeutic areas: Metastatic Breast Cancer, Acute Myelogenous Leukemia, Ovarian Cancer.
Sponsors: Eli Lilly and Company, Sellas Life Sciences Group, Memorial Sloan Kettering Cancer Center.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Memorial Sloan Kettering Cancer Center has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Memorial Sloan Kettering Cancer Center has 10 clinical trials on record, with 3 currently active. Their work covers Metastatic Breast Cancer, Acute Myelogenous Leukemia, Ovarian Cancer.
Yes — Memorial Sloan Kettering Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.